01 10GILEAD SCIENCES INC
02 8JANSSEN PRODS
03 7VIIV HLTHCARE
01 97125879
02 17390791
03 18129385
04 18754065
05 18841310
06 19242986
07 19296769
08 110426780
09 110857102
10 111065198
11 112011506
12 17125879*PED
13 17390791*PED
14 18129385*PED
15 18754065*PED
16 19242986*PED
17 19296769*PED
01 15Y
02 10Blank
01 19Y
02 6Blank
01 12025-01-07
02 92025-04-21
03 12025-07-07
04 12025-10-21
05 12025-12-09
06 12027-10-05
07 12028-04-05
08 12029-12-08
09 12030-06-08
10 12031-01-24
11 22032-08-15
12 12033-01-14
13 22033-02-15
14 12037-10-23
15 12038-09-05
Patent Expiration Date : 2032-08-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2025-12-09
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8841310
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-12-09
Patent Expiration Date : 2032-08-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2025-04-21
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 7125879
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-04-21
Patent Expiration Date : 2025-04-21
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 7125879
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-04-21
Patent Expiration Date : 2033-01-14
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 10857102
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-01-14
Patent Expiration Date : 2025-01-07
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 7390791
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-01-07
Patent Expiration Date : 2033-02-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 208351
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-15
Patent Expiration Date : 2025-07-07
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 7390791*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 208351
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-07-07
Patent Expiration Date : 2033-02-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 208351
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-15
